| 摘要 |
<p>Disclosed is a therapeutic agent for unstable cerebrospinal pressure syndrome. It is found that there exists a disease induced by a large fluctuation and instability in a cerebrospinal pressure compared to that in normal persons, and the disease is named "unstable cerebrospinal pressure syndrome". The therapeutic agent comprises a carbonic anhydrase inhibitor as an active ingredient and is effective on unstable cerebrospinal pressure syndrome. Since a carbonic anhydrase inhibitor can inhibit the enzymatic activity of carbonic anhydrase and therefore is effective for stabilization of a cerebrospinal pressure, the inhibitor can be used for the prevention/treatment of unstable cerebrospinal pressure syndrome.</p> |
